RxDoctor Payments Data

George Pankey

Infectious Disease · New Orleans, LANPI 1609822956

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,550 of the $2,564 with a category attached, or 99.4%. Abbott accounts for 99.4% of it on its own, with 1 other manufacturer making up the rest.

$2,564in general payments, 2019–2025

Across 2 payments — averaging $1282.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Paratek Pharmaceuticals, Inc.$14
$848,870in research payments, 2019–2025

Across 2 payments — averaging $424,435 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • T2 Biosystems, Inc.$849K

What the payments were for

  • Consulting fees$2,55099%
  • Food & beverage$141%

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott1$2,550
Paratek Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,564 in reported general payments places this provider in the 70th percentile of 105 infectious disease providers in Louisiana.

See all infectious disease providers in Louisiana

Other infectious disease in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →